
CAS 1251765-07-7
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
11 prodotti.
Ticagrelor Amine ((1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C14H22N6O4SColore e forma:Off-White PowderPeso molecolare:370.142321,2-Cyclopentanediol, 3-[7-amino-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-
CAS:Formula:C14H22N6O4SPurezza:99%Colore e forma:SolidPeso molecolare:370.4273Ticagrelor EP Impurity A
CAS:Formula:C14H22N6O4SColore e forma:White To Off-White SolidPeso molecolare:370.43(1S,2S,3R,5S)-3-(7-Amino-5-(Propylthio)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-3-Yl)-5-(2-Hydroxyethoxy)Cyclopentane-1,2-Diol
CAS:(1S,2S,3R,5S)-3-(7-Amino-5-(Propylthio)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-3-Yl)-5-(2-Hydroxyethoxy)Cyclopentane-1,2-DiolPurezza:98%Peso molecolare:370.43g/molTicagrelor metabolite M5
CAS:Ticagrelor metabolite M5 (T437700) is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor.Formula:C14H22N6O4SPurezza:99.35%Colore e forma:SolidPeso molecolare:370.43Ref: ST-EA-CP-T21001
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaAR-C133913XX
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications AR-C133913XX is an metabolte of Ticagrelor (T437700) which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Ticagrelor is used in the treatment of acute coronary syndromes (ACS).<br>References Matetzky, S., et al.: Circulation, 109, 3171 (2004); Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007); Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007)<br></p>Formula:C14H22N6O4SColore e forma:NeatPeso molecolare:370.43AR-C133913XX
CAS:<p>AR-C133913XX is a dietary supplement that belongs to the group of drugs known as adenosine receptor antagonists. It is used to treat cardiovascular diseases such as hypertension, coronary artery disease, and heart failure. AR-C133913XX reversibly blocks the A2A adenosine receptor in the caco-2 cells in order to reduce blood flow and increase vasoconstriction. This drug also has antiplatelet properties, which are due to its ability to inhibit platelet aggregation. AR-C133913XX is metabolized by glucuronidation and eliminated by renal excretion.</p>Formula:C14H15N6O4SPurezza:Min. 95%Colore e forma:PowderPeso molecolare:370.43 g/mol(1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
CAS:Purezza:99%Peso molecolare:370.4299927AR-C133913XX-d7
CAS:Prodotto controllatoFormula:C14D7H15N6O4SColore e forma:NeatPeso molecolare:377.47









